Ocugen (OCGN) Operating Leases (2019 - 2026)
Ocugen (OCGN) reported Operating Leases of $3.3 million for Q1 2026, down 4.86% on a YoY basis from $3.4 million in Q1 2025, and down 6.93% quarter-over-quarter from $3.5 million in Q4 2025.
Ocugen (OCGN) Operating Leases (2019 - 2026) Analysis & Trends
Ocugen has reported Operating Leases for 8 years, with the latest figure at $3.3 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases fell 4.86% year-over-year to $3.3 million; the trailing twelve-month figure through Mar 2026 stood at $3.3 million (down 4.86% YoY), and the FY2025 full-year result was $3.5 million, up 5.46% from the prior year.
- Operating Leases for Q1 2026 stood at $3.3 million, down from $3.5 million in the prior quarter.
- The five-year high for Operating Leases was $4.1 million in Q4 2023, with the low at $1.2 million in Q1 2022.
- Historically, Operating Leases has averaged $3.5 million across 5 years, with a median of $3.4 million in 2023.
- The largest YoY upside for Operating Leases was 194.06% in 2022 against a maximum downside of 23.33% in 2022.
- Ocugen's Operating Leases stood at $4.1 million in 2022, then rose by 1.37% to $4.1 million in 2023, then fell by 20.0% to $3.3 million in 2024, then advanced by 5.46% to $3.5 million in 2025, then declined by 6.93% to $3.3 million in 2026.
- The last three Operating Leases figures came in at $3.3 million (Q1 2026), $3.5 million (Q4 2025), and $3.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.25 Mn |
| Dec 31, 2025 | 3.49 Mn |
| Sep 30, 2025 | 3.71 Mn |
| Jun 30, 2025 | 3.95 Mn |
| Mar 31, 2025 | 3.42 Mn |
| Dec 31, 2024 | 3.31 Mn |
| Sep 30, 2024 | 3.42 Mn |
| Jun 30, 2024 | 4.01 Mn |
| Mar 31, 2024 | 3.41 Mn |
| Dec 31, 2023 | 4.14 Mn |
| Sep 30, 2023 | 3.16 Mn |
| Jun 30, 2023 | 3.31 Mn |
| Mar 31, 2023 | 3.45 Mn |
| Dec 31, 2022 | 4.09 Mn |
| Sep 30, 2022 | 3.76 Mn |
| Jun 30, 2022 | 3.89 Mn |
| Mar 31, 2022 | 1.18 Mn |
| Dec 31, 2021 | 1.59 Mn |
| Sep 30, 2021 | 1.28 Mn |
| Jun 30, 2021 | 1.33 Mn |